GPD1L and hepatocellular carcinoma: We analysed the GDSC dataset, which includes FDA-approved drugs potentially not well-studied in HCC, using correlation analysis to identify novel associations with GPD1L expression in HCC cell lines, aiming to uncover unexplored connections and insights into treatment responses.